Valuation: MindMaze Therapeutics Holding SA

Market Cap 24.11M 29.5M 25.91M 22.11M 41.56M 2.85B 42.2M 286M 112M 1.4B 111M 108M 4.83B P/E 2026 *
-3.51x
P/E 2027 * 1.23x
Enterprise Value 15.69M 19.2M 16.86M 14.39M 27.05M 1.86B 27.47M 186M 72.77M 909M 72.1M 70.57M 3.14B EV / Sales 2026 *
2.66x
EV / Sales 2027 * 0.11x
Free-Float
38.51%
Yield 2026 *
-
Yield 2027 * -
1 day+3.67%
1 week-1.99%
Current month-21.00%
1 month-28.18%
3 months-47.51%
6 months-86.68%
Current year-91.68%
1 week 0.15
Extreme 0.1518
0.17
1 month 0.15
Extreme 0.1518
0.26
Current year 0.15
Extreme 0.1518
1.87
1 year 0.15
Extreme 0.1518
2.92
3 years 0.15
Extreme 0.1518
2.92
5 years 0.15
Extreme 0.1518
2.92
10 years 0.15
Extreme 0.1518
2.92
Date Insider Type Main position Quantity % Market Cap.
19/12/25 Sell 52,162 0.0338%
19/12/25 Sell 281,968 0.1830%
19/12/25 Sell 140,000 0.0908%
Change 5-day change 1-year change 3-year change Capi.($)
+3.67%-1.99% - - 29.52M
+1.07%-3.49%-3.35%+10.44% 46.86B
+0.25%+1.65%+399.22%+634.87% 40.23B
-0.27%+4.45%+11.81%+65.64% 36.23B
+0.35%+0.87%+4.46%-10.16% 34.72B
+3.14%+1.02%+4.76%+40.92% 27.89B
-0.73%+11.84%+34.39%+134.36% 16.79B
+0.47%-2.74% - - 16.74B
+0.42%-5.52%-3.43%+9.03% 13.12B
-2.68%-2.49%-11.36%-33.61% 12.7B
Average +0.57%+0.55%+54.56%+106.44% 24.53B
Weighted average by Cap. +0.48%+0.91%+74.42%+136.27%

Financials

2026 *2027 *
Net sales 5.9M 7.22M 6.34M 5.41M 10.17M 697M 10.33M 69.95M 27.36M 342M 27.11M 26.53M 1.18B 43.19M 52.85M 46.4M 39.6M 74.44M 5.11B 75.59M 512M 200M 2.5B 198M 194M 8.65B
Net income -7.81M -9.56M -8.39M -7.16M -13.46M -923M -13.67M -92.6M -36.22M -453M -35.89M -35.13M -1.57B 24.83M 30.38M 26.68M 22.76M 42.79M 2.94B 43.45M 294M 115M 1.44B 114M 112M 4.98B
Net Debt -8.42M -10.3M -9.05M -7.72M -14.51M -995M -14.74M -99.81M -39.04M -488M -38.68M -37.86M -1.69B -19.27M -23.58M -20.7M -17.67M -33.21M -2.28B -33.73M -228M -89.36M -1.12B -88.54M -86.65M -3.86B
Logo MindMaze Therapeutics Holding SA
MindMaze Therapeutics Holding SA, formerly known as RELIEF THERAPEUTICS Holding SA, is a Switzerland-based company that engages in research, development, production, and sale of biotechnology, pharmaceutical, diagnostic, therapeutic, chemical, and cosmetic products. The Company acquires and manages patents, licenses, and intellectual property, provides preclinical, clinical, and regulatory services, and may establish subsidiaries worldwide. The Company also participates in the acquisition, holding, and financing of interests in companies, offers management services to affiliates, and develops scientific and economic solutions for disease treatment and therapeutic approaches. Additionally, the Company may acquire, hold, and sell trademarks and other IP rights globally, and provide or obtain financing through loans or guarantees to support its corporate purpose.
Employees
10
Date Price Change Volume
24/07/26 CHF 0.1580 +3.67% 931,243
23/07/26 CHF 0.1524 -3.42% 465,585
22/07/26 CHF 0.1578 +0.38% 946,836
21/07/26 CHF 0.1572 -0.25% 484,462
20/07/26 CHF 0.1576 -2.23% 616,675
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Annual profits - Rate of surprise